PC
BLACU

Periscope Capital’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

Periscope Capital’s Portfolio BLACU Stock Details BLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-588,623
Closed -$6.33M – 633
2023
Q2 		$6.33M Hold
588,623
– – 0.49% 56
2023
Q1 		$6.07M Buy
+588,623
New +$6.03M 0.28% 129

Other funds holding BLACU

HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Periscope Capital's BLACU Position: Q3 2023 in Review

Periscope Capital sold out of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) in Q3 2023, closing a stake of 588,623 shares — an estimated $6.33M sold.

Periscope Capital first reported a position in BLACU in Q1 2023 and held it in 2 quarters. The position peaked at $6.33M in Q2 2023. 10 funds tracked by Wall St. Rank hold BLACU as of Q3 2023.

  • Periscope Capital reported no remaining Bellevue Life Sciences Acquisition Corp. Unit position as of Q3 2023 after selling out during the quarter.
  • Periscope Capital sold 588,623 Bellevue Life Sciences Acquisition Corp. Unit shares in Q3 2023, an estimated $6.33M.
  • Periscope Capital first reported a position in Bellevue Life Sciences Acquisition Corp. Unit in Q1 2023 and held it in 2 quarters.
  • Periscope Capital's Bellevue Life Sciences Acquisition Corp. Unit position peaked at $6.33M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Unit as of Q3 2023.

Based on Periscope Capital's 13F filing for Q3 2023, filed 6 Nov 2023.